skip to main content
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF-BNLI Criteria
Material Type:
Article
Add to e-Shelf

Fractionated 90Y-Ibritumomab Tiuxetan Radioimmunotherapy as an Initial Therapy of Follicular Lymphoma: An International Phase II Study in Patients Requiring Treatment According to GELF-BNLI Criteria

Illidger TM, Mayes S, Pettengell R, Bates AT, Bayne M, Radford JA, Ryder WD, Le Gouill S, Jardin F, Tipping J, Zivanovic M, Kraeber-Bodere F, Bardies M, Bodet-Milin C, Malek E, Huglo D, Morschhauser F 2014

Full text available

Personalize your results

  1. Edit

Refine Search Results

Expand My Results

  1.   

Searching Remote Databases, Please Wait